Episurf Medical (Nasdaq: EPIS B) today announces that an abstract with results from follow-up of Episealer® Knee implant patients will be presented by Priv.-Doz. Dr. med. Clemens Kösters at the 38th annual AGA Congress in Innsbruck, Austria, which will take place on September 9-11.

The abstract with the title “Good clinical results after implantation of single vs. multiple patient-specific mini-implants in therapy-resistant focal femoral (osteo-) chondral lesions in middle-aged patients” presents the clinical outcome for patients who received multiple Episealer® implants compared with the results for patients who received one Episealer® implant for treatment of focal chondral and osteochondral defects in the knee.

“Our results astonishingly demonstrated that the clinical results of patients with 2 or 3 Episealer® implants were just as good as those with 1 Episealer® implant. Furthermore, both groups did not show any complications” says Priv.-Doz. Dr. med. Clemens Kösters.

“The use of 2-3 implants has become relatively frequent among some of the Episealer® surgeons, but publications of clinical follow-up data are limited. We look forward to seeing the results from this independent group of authors presented at this important congress” says Pål Ryfors, CEO Episurf Medical.

AGA-Society for Arthroscopy and Joint-Surgery is a German speaking scientific organisation and one of Europe’s largest professional organisations within arthroscopy and joint-surgery.